View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Immunosuppressant

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Allos Therapeutics Announces New Data on FOLOTYN(TM) to be Presented at the American Society of Hematology Meeting

2009 NOV 23 ... Cancer, Clinical Trial Research, Cutaneous T-Cell Lymphoma, Gemcitabine, Hematology, Immunosuppressant, Mucositis, Oncology, Peripheral T-Cell Lymphoma, Radiation-Sensitizing Agent, ...

Subject: Allos Therapeutics, Inc.

Price: $3.00

BARACLUDE(R) entecavir Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis

2009 NOV 16 ... with BARACLUDE in a liver transplant recipient who has received or is receiving an immunosuppressant that may affect renal function, such as cyclosporine or tacrolimus. Since ...

Subject: Bristol-Myers Squibb

Price: $3.00

Ligand's JAK3 Research Collaboration Extended by Pfizer

2009 NOV 16 ... to hematopoietic cells, and specific inhibitors of JAK3 could represent a new class of immunosuppressant drugs. About Ligand Pharmaceuticals Ligand discovers and develops new drugs that address ...

Subject: Ligand Pharmaceuticals Incorporated

Price: $3.00

New stem cell research study results reported from Emory University

2009 NOV 16 ... 2.5, and 5 mu L/min, respectively. Groups 4 and 5 (n = 3 pigs each) received prolonged immunosuppressant pretreatment in an attempt to demonstrate graft viability. The latter was undertaken in ...

Subject: Stem Cell Research

Price: $3.00

Research conducted at Fudan University has provided new information about pancreatic cancer

2009 NOV 9 ... Antimetabolite, Antineoplastic, Antiviral, Circulation, Gastroenterology, Gemcitabine, Immunosuppressant, Oncology, Pancreas, Pancreatic Cancer, Pancreatic Neoplasms, Pharmaceuticals, ...

Subject: Pancreatic Cancer

Price: $3.00

Research findings from M. Aouida et al update understanding of life sciences

2009 NOV 9 ... additional genome-wide screens designed to identify mutants that are sensitive to the immunosuppressant rapamycin and the divalent metal ion zinc. However, the role of Opt2 in protecting cells ...

Subject: Life Sciences

Price: $3.00

Research from University of California yields new data on cervical cancer

2009 NOV 9 ... Cisplatin, Clinical Oncology, Drugs, Enzyme Inhibitor, Gemcitabine, Gynecology, Immunosuppressant, Oncology, Paclitaxel, Pharmaceuticals, Quality of Life, Radiation-Sensitizing Agent, ...

Subject: Cervical Cancer

Price: $3.00

Research from University of Kansas has provided new data on kidney cancer

2009 NOV 9 ... Oncology, Clinical Trial Research, Drug Therapy, Drugs, Enzyme Research, Gemcitabine, Immunosuppressant, Kidney, Nephrology, Oncology, Pharmaceuticals, Radiation-Sensitizing Agent, Renal ...

Subject: Kidney Cancer

Price: $3.00

Researchers from Ohio State University publish new studies and findings in the area of pancreatic cancer

2009 NOV 9 ... Cell Proliferation, Chemotherapy, Drug Therapy, Gastroenterology, Gemcitabine, Immunosuppressant, Oncology, Pancreas, Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Neoplasms, ...

Subject: Pancreatic Cancer

Price: $3.00

Researchers from Tokai University, Department of Surgery provide details of new studies and findings in the area of breast cancer therapy

2009 NOV 23 ... Cancer, Breast Carcinoma, Clinical Oncology, Clinical Trial Research, Gemcitabine, Immunosuppressant, Oncology, Radiation-Sensitizing Agent, Surgery, Therapy, Treatment, Women's Health. ...

Subject: Breast Cancer Therapy

Price: $3.00

Researchers from University of Edinburgh publish findings in ovarian cancer

2009 NOV 16 ... Antiviral, Biotechnology, Clinical Trial Research, Gemcitabine, Gynecology, Immunosuppressant, Immunotherapy, Monoclonal Antibodies, Oncology, Ovarian Cancer, Ovarian Carcinoma, ...

Subject: Ovarian Cancer

Price: $3.00

Studies conducted at National Cancer Center Hospital on acinar cell cancer therapy recently published

2009 NOV 23 ... Antineoplastic, Antiviral, Clinical Oncology, Gastroenterology, Gemcitabine, Immunosuppressant, Oncology, Pancreas, Pancreatic Cancer, Pancreatic Neoplasms, Radiation-Sensitizing ...

Subject: Acinar Cell Cancer Therapy

Price: $3.00

Studies from H. Eguchi et al add new findings in the area of pancreatic cancer

2009 NOV 9 ... Antiviral, Chemotherapy, Drug Resistance, Drug Therapy, Gastroenterology, Gemcitabine, Immunosuppressant, Oncology, Pancreas, Pancreatic Cancer, Pancreatic Neoplasms, Radiation-Sensitizing ...

Subject: Pancreatic Cancer

Price: $3.00

Studies from Kyoto University reveal new findings on neutropenia therapy

2009 NOV 16 ... Clinical Trial Research, Docetaxel, Drug Therapy, Drugs, Gemcitabine, Hematology, Immunosuppressant, Infectious Disease, Lung Neoplasms, Neutropenia, Non-Small Cell Lung Cancer, Non-Small ...

Subject: Neutropenia Therapy

Price: $3.00

Studies in the area of biomedicine reported from University of Ulsan

2009 NOV 16 ... According to a study from Seoul, South Korea, "The use of immunosuppressant after liver transplantation makes transplant recipients susceptible to infections. Most ...

Subject: Biomedicine

Price: $3.00

Study data from University of Paris update understanding of cancer

2009 NOV 23 ... Antiviral, Apoptosis, Clinical Trial Research, Clinical Trials, Enzymes, Gemcitabine, Immunosuppressant, Molecular Pharmacology, Molecular Therapies, Nucleoside Analog, Oncology, ...

Subject: Cancer

Price: $3.00

Study findings from University of Central Florida provide new insights into pancreatic cancer

2009 NOV 16 ... Antiviral, Apoptosis, Experimental Design, Gastroenterology, Gemcitabine, Immunosuppressant, Oncology, Pancreas, Pancreatic Cancer, Pancreatic Neoplasms, Protein Expression, ...

Subject: Pancreatic Cancer

Price: $3.00

Study findings on transplantation are outlined in reports from B. Gyurkocza and colleagues

2009 NOV 9 ... Transplantation, Drugs, Fludarabine, Hematologic Disease, Hematology, Hematopoietic, Immunosuppressant, Kidney, Medical Device, Myelofibrosis, Nephrology, Oncology, Organ Transplant, Renal ...

Subject: Transplantation

Price: $3.00

Study results from Ohio State University provide new insights into chronic lymphocytic leukemia

2009 NOV 9 ... Drug Development, Drug Resistance, Drugs, Enzyme Research, Fludarabine, Hematology, Immunosuppressant, Kinase, Lymphoma, Myeloma, Oncology, Pharmaceuticals, Pharmacokinetics, Therapies, ...

Subject: Chronic Lymphocytic Leukemia

Price: $3.00

Visits by Canine Therapists Lift Patients' Spirits at Stanford Hospital

2009 NOV 16 ... At no time are the dogs off leash. Nor do they go to units where patients are on immunosuppressant medications. The visits with each patient last between five and 10 minutes. Black ...

Subject: Stanford Hospital

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx